Investment platform
Русский
Беларускі
Español
Biogen
Sell122.59
Spread0.44
Buy123.03

Trade Biogen Inc. - BIIB stock price

Sell122.59
Spread0.44
Buy123.03
1m
5m
15m
30m
1H
4H
1D
1W
History
122.59
Open on platform
Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies. The company's Phase II clinical trial products comprise Opicinumab for MS; BAN2401 for Alzheimer's disease; BIIB092 for PSP; Natalizumab for Acute Ischemic Stroke and Epilepsy; and BG00011 for idiopathic pulmonary fibrosis. Its Phase I/IIa clinical trial products consist of BIIB080 for patients with mild AD. The company's Phase I clinical trial products comprise Aducanumab for Alzheimer's disease; BIIB076, an anti-tau monoclonal antibody; and BIIB054 for Parkinson's disease. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play None Explore platform Show QR
Articles
Crypto braces for Trump’s tariff announcment: what to expect
Read more
‘Typical Justin Sun smear campaign’: First Digital denies allegations, threatens legal action
Read more
AI tokens Bittensor, Render, Grass plunge after key Microsoft news
Read more
MARA’s mining pool drives March surge in BTC production and rewards
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

BIIB price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
Apr 4, 2025 122.59 -5.91 -4.60 128.5 122.04 129.42
Apr 3, 2025 130.25 -0.97 -0.74 131.22 129.86 132.84
Apr 2, 2025 131.07 -0.88 -0.67 131.95 128.45 133.47
Apr 1, 2025 131.83 -4.57 -3.35 136.4 131.16 136.87
Mar 31, 2025 136.71 -0.42 -0.31 137.13 134.49 137.31
Mar 28, 2025 137.87 -2.35 -1.68 140.22 137.87 140.87
Mar 27, 2025 139.84 -2.48 -1.74 142.32 139.56 143.8
Mar 26, 2025 142.19 3.09 2.22 139.1 138.95 142.76
Mar 25, 2025 139.08 -3.03 -2.13 142.11 138.46 142.11
Mar 24, 2025 141.34 0.00 0.00 141.34 140.4 143.91
Mar 21, 2025 140.82 -0.31 -0.22 141.13 138.91 141.68
Mar 20, 2025 140.92 0.00 0.00 140.92 140.28 142.73
Mar 19, 2025 140.95 -1.82 -1.27 142.77 140.3 143.78
Mar 18, 2025 142.97 0.05 0.03 142.92 142.6 145.59
Mar 17, 2025 143.44 4.75 3.42 138.69 138.49 143.65
Mar 14, 2025 139.04 -0.01 -0.01 139.05 138.26 140.58
Mar 13, 2025 139.77 0.67 0.48 139.1 138.8 143.19
Mar 12, 2025 139.96 -1.91 -1.35 141.87 139.73 142.81
Mar 11, 2025 143.43 -6.22 -4.16 149.65 141.9 151.02
Mar 10, 2025 150.42 0.41 0.27 150.01 149.91 156.84
Go help.dzengi.com
Dzengi.com Exchange
Trade BTC & tokenized stocks